A study to compare two different aramchol formulations in healthy volunteers.
CGA23001
Phase 1 other active
Quick answer
A study to compare two different aramchol formulations in healthy volunteers. for Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Primary sclerosing cholangitis is a Phase 1 program (other) at Galmed Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Galmed Pharmaceuticals
- Indication
- Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Primary sclerosing cholangitis
- Phase
- Phase 1
- Modality
- other
- Status
- active